Amneal Pharmaceuticals (AMRX) Free Cash Flow (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Free Cash Flow of -$34.9 million for Q1 2026, down 506.85% year-over-year from $8.6 million in Q1 2025, and down 132.17% quarter-over-quarter from $108.5 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Free Cash Flow (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$34.9 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 506.85% year-over-year to -$34.9 million; the TTM figure through Mar 2026 stood at $240.8 million (down 4.09% YoY), while the FY2025 annual figure was $269.9 million, up 11.0% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$34.9 million, down from $108.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $130.0 million in Q1 2023, with the low at -$130.6 million in Q2 2022.
- The 5-year median for Free Cash Flow is $69.7 million (2023), against an average of $47.0 million.
- The sharpest annual moves came in 2023 and 2026: Free Cash Flow surged 462.39% in 2023, then plunged 506.85% in 2026.
- Amneal Pharmaceuticals' Free Cash Flow stood at -$34.8 million in 2022, then soared by 462.39% to $126.0 million in 2023, then declined by 18.29% to $102.9 million in 2024, then increased by 5.46% to $108.5 million in 2025, then plunged by 132.17% to -$34.9 million in 2026.
- Business Quant data shows AMRX's Free Cash Flow at -$34.9 million in Q1 2026, $108.5 million in Q4 2025, and $106.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | -51.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -51.94 Mn |
| Jun 30, 2026 | -51.94 Mn |
| Mar 31, 2026 | -34.92 Mn |
| Mar 31, 2026 | -34.92 Mn |
| Dec 31, 2025 | 108.54 Mn |
| Dec 31, 2025 | 108.54 Mn |
| Sep 30, 2025 | 106.15 Mn |
| Sep 30, 2025 | 106.15 Mn |
| Jun 30, 2025 | 60.99 Mn |
| Jun 30, 2025 | 60.99 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Dec 31, 2024 | 102.92 Mn |
| Dec 31, 2024 | 102.92 Mn |
| Sep 30, 2024 | 124.83 Mn |
| Sep 30, 2024 | 124.83 Mn |
| Jun 30, 2024 | 29.03 Mn |
| Jun 30, 2024 | 29.03 Mn |
| Mar 31, 2024 | -13.61 Mn |
| Mar 31, 2024 | -13.61 Mn |